Li H - Search Results

1

[Expression of CD133+ endothelial progenitor cell in rat periodontal tissue during tooth movement].

Li H, Sun XH, Liu C. Li H, et al. Hua Xi Kou Qiang Yi Xue Za Zhi. 2010 Oct;28(5):468-70, 474. Hua Xi Kou Qiang Yi Xue Za Zhi. 2010. PMID: 21179675 Chinese.

2

[Efficacy and safety of high-dose α-lipoic acid in the treatment of diabetic polyneuropathy].

Gu XM, Zhang SS, Wu JC, Tang ZY, Lu ZQ, Li H, Liu C, Chen L, Ning G. Gu XM, et al. Among authors: li h. Zhonghua Yi Xue Za Zhi. 2010 Sep 21;90(35):2473-6. Zhonghua Yi Xue Za Zhi. 2010. PMID: 21092474 Clinical Trial. Chinese.

3

A Phase 1, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Safety, Tolerability, And Pharmacokinetic/Pharmacodynamic Study Of Evolocumab In Healthy Chinese Subjects.

Liu C, Lu H, Yuan F, Chen WL, Xu HR, Li H, Hsu CP, Egbuna O, Wu J, Dias C, Abosaleem B, Rana J, Monsalvo ML, Li XN, Yu Z. Liu C, et al. Among authors: li h, li xn. Clin Pharmacol. 2019 Oct 23;11:145-153. doi: 10.2147/CPAA.S208033. eCollection 2019. Clin Pharmacol. 2019. PMID: 31695519 Free PMC article.

4

Pharmacokinetics of Icosapent Ethyl: An Open-Label, Multiple Oral Dose, Parallel Design Study in Healthy Chinese Subjects.

Yuan F, Li H, Yang M, Chen W, Chen H, Xu H, Li J, Sheng L, Liu C, Li Y, Li H, Li X. Yuan F, et al. Among authors: li y, li j, li h, li x. Clin Pharmacol Drug Dev. 2023 Jan;12(1):6-13. doi: 10.1002/cpdd.1130. Epub 2022 Jul 3. Clin Pharmacol Drug Dev. 2023. PMID: 35781804 Clinical Trial.

5

Pharmacokinetics, Safety and Tolerability of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein (CETP) Inhibitor, After Single and Multiple Doses in Healthy Chinese Subjects.

Chen H, Chen W, Li H, Xu H, Yuan F, Sheng L, Liu C, Lin P, Yang M, Li X, Liu Y, Walker BM, Gheyas F, Iwamoto M, Stoch SA, Krishna R. Chen H, et al. Among authors: li h, li x. Adv Ther. 2021 Jul;38(7):3973-3985. doi: 10.1007/s12325-021-01794-8. Epub 2021 Jun 8. Adv Ther. 2021. PMID: 34101144

6

Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects.

Sheng L, Cao W, Lin P, Chen W, Xu H, Zhong C, Yuan F, Chen H, Li H, Liu C, Yang M, Li X. Sheng L, et al. Among authors: li h, li x. Drug Des Devel Ther. 2021 Mar 9;15:1101-1110. doi: 10.2147/DDDT.S296197. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33727798 Free PMC article. Clinical Trial.

7

Platelet inhibitory activity, tolerability, and safety of vicagrel, a novel thienopyridine P2Y12 inhibitor.

Li H, Chen H, Chen W, Xu H, Yuan F, Yang M, Sun H, Yang J, Liu Y, Lai X, Gong Y, Liu X, Li Y, Sheng L, Liu C, Li X. Li H, et al. Among authors: li y, li x. Medicine (Baltimore). 2020 Jan;99(4):e18683. doi: 10.1097/MD.0000000000018683. Medicine (Baltimore). 2020. PMID: 31977858 Free PMC article. Clinical Trial.

8

Prognostic value of programmed cell death ligand 1 (PD-L1) for hepatocellular carcinoma: a meta-analysis.

Li XS, Li JW, Li H, Jiang T. Li XS, et al. Among authors: li jw, li h. Biosci Rep. 2020 Apr 30;40(4):BSR20200459. doi: 10.1042/BSR20200459. Biosci Rep. 2020. PMID: 32255189 Free PMC article.

9

Comparison of allo-SCT, auto-SCT and chemotherapy for the treatment of patients with low- or intermediate-risk acute myeloid leukemia: a network meta-analysis.

Ye W, Wu X, Zhao R, Jin X, Li H, Qu Y, Ji J, Liu Z. Ye W, et al. Among authors: li h. Stem Cell Res Ther. 2024 May 31;15(1):153. doi: 10.1186/s13287-024-03766-5. Stem Cell Res Ther. 2024. PMID: 38816870

10

Current applications of intestinal organoids: a review.

Xiang T, Wang J, Li H. Xiang T, et al. Among authors: li h. Stem Cell Res Ther. 2024 May 31;15(1):155. doi: 10.1186/s13287-024-03768-3. Stem Cell Res Ther. 2024. PMID: 38816841 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113,102 results

Search Page